vimarsana.com

Page 9 - மருத்துவ ஆராய்ச்சி வலைப்பின்னல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Low- and high-dose aspirin achieve similar protection, safety for those with heart disease

Credit: PCORI WASHINGTON, DC People with cardiovascular disease (CVD) taking aspirin to lower their chances of suffering a heart attack or stroke experienced similar health benefits, including reduced death and hospitalization for heart attack and stroke, whether they took a high or low dose of aspirin, according to a study presented today at ACC.21, the American College of Cardiology s 70th Annual Scientific Session and published in the New England Journal of Medicine. CVD and atherosclerosis, in particular, which is a narrowing and hardening of the arteries is a leading cause of death for men, women, and most racial and ethnic groups in the United States, with estimated direct costs of $214 billion, according to the American Heart Association. Millions of Americans with CVD take recommended aspirin therapy to help reduce their risk of heart attack and stroke, a decades-long practice that has, until now, lacked definitive research studying the doses that work best for patients a

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.

Baby and Regular Strength Aspirin Equal in Cardiac Platelet Inhibition and Safety

Screening for ovarian cancer did not reduce deaths during study

Screening for ovarian cancer did not reduce deaths during study ANI | Updated: May 14, 2021 09:29 IST London [UK], May 14 (ANI): A large-scale randomised trial of annual screening for ovarian cancer, led by UCL researchers, did not succeed in reducing deaths from the disease, despite one of the screening methods tested detecting cancers earlier. Results from the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) have been published in a report in the medical journal The Lancet. In the UK, 4,000 women die from ovarian cancer each year. It is not usually diagnosed until it is at a late stage and hard to treat. UKCTOCS was designed to test the hypothesis that a reliable screening method that picks up ovarian cancer earlier can save lives when treatments are more likely to be effective.

ACC 21 Looks to Repeat Success Despite Pandemic Headwinds

ACC 21 Looks to Repeat Success Despite Pandemic Headwinds
medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.